Correlation Between Cardio Diagnostics and Acumen Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Cardio Diagnostics and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Acumen Pharmaceuticals.

Diversification Opportunities for Cardio Diagnostics and Acumen Pharmaceuticals

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cardio and Acumen is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Acumen Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and Acumen Pharmaceuticals

Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to under-perform the Acumen Pharmaceuticals. In addition to that, Cardio Diagnostics is 1.79 times more volatile than Acumen Pharmaceuticals. It trades about -0.03 of its total potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about 0.01 per unit of volatility. If you would invest  272.00  in Acumen Pharmaceuticals on September 4, 2024 and sell it today you would lose (44.00) from holding Acumen Pharmaceuticals or give up 16.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  Acumen Pharmaceuticals

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cardio Diagnostics Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Cardio Diagnostics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Acumen Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Acumen Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Acumen Pharmaceuticals is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Cardio Diagnostics and Acumen Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and Acumen Pharmaceuticals

The main advantage of trading using opposite Cardio Diagnostics and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.
The idea behind Cardio Diagnostics Holdings and Acumen Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Directory
Find actively traded commodities issued by global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon